IPSC · Century Therapeutics Inc
United States · RS rating 16 · As of 2026-10-14
| Price | 1.38 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 6 / 8 / 97 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 26 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -54.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +53.1% |
| Market cap (USD) | $406.2M |